|
1
|
Shen Z, Li Q, Deng H, Lu D, Song H and Guo
J: Long non-coding RNA profiling in laryngeal squamous cell
carcinoma and its clinical significance: Potential biomarkers for
LSCC. PLoS One. 9:e1082372014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Almadori G, Bussu F, Cadoni G, Galli J,
Paludetti G and Maurizi M: Molecular markers in laryngeal squamous
cell carcinoma: Towards an integrated clinicobiological approach.
Eur J Cancer. 41:683–693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Su Z, Li G, Yu C, Ren S, Huang D,
Fan S, Tian Y, Zhang X and Qiu Y: Increased expression of
metadherin protein predicts worse disease-free and overall survival
in laryngeal squamous cell carcinoma. Int J Cancer. 133:671–679.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma J, Wang J, Fan W, Pu X, Zhang D, Fan C,
Xiong L, Zhu H, Xu N, Chen R and Liu S: Upregulated TIMP-1
correlates with poor prognosis of laryngeal squamous cell
carcinoma. Int J Clin Exp Pathol. 7:246–254. 2013.PubMed/NCBI
|
|
5
|
Rodrigo JP, Coca-Pelaz A and Suárez C: The
current role of partial surgery as a strategy for functional
preservation in laryngeal carcinoma. Acta Otorrinolaringol Esp.
62:231–238. 2011.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ajithkumar T, Price S, Horan G, Burke A
and Jefferies S: Prevention of radiotherapy-induced neurocognitive
dysfunction in survivors of paediatric brain tumours: The potential
role of modern imaging and radiotherapy techniques. Lancet Oncol.
18:e91–e100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mountzios G, Kostopoulos I, Kotoula V,
Sfakianaki I, Fountzilas E, Markou K, Karasmanis I, Leva S,
Angouridakis N, Vlachtsis K, et al: Insulin-like growth factor 1
receptor (IGF1R) expression and survival in operable squamous-cell
laryngeal cancer. PLoS One. 8:e540482013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Messina JL, Fenstermacher DA, Eschrich S,
Qu X, Berglund AE, Lloyd MC, Schell MJ, Sondak VK, Weber JS and
Mulé JJ: 12-Chemokine gene signature identifies lymph node-like
structures in melanoma: Potential for patient selection for
immunotherapy? Sci Rep. 2:7652012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitkin NA, Hook CD, Schwartz AM, Biswas S,
Kochetkov DV, Muratova AM, Afanasyeva MA, Kravchenko JE,
Bhattacharyya A and Kuprash DV: p53-dependent expression of CXCR5
chemokine receptor in MCF-7 breast cancer cells. Sci Rep.
5:93302015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Richmond A and Thomas HG: Melanoma growth
stimulatory activity: Isolation from human melanoma tumors and
characterization of tissue distribution. J Cell Biochem.
36:185–198. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao H, Zhu H, Jin Q, Zhang S, Wang W,
Wang D and Huang J: Association of high expression of Groβ with
clinical and pathological characteristics of unfavorable prognosis
in gastrointestinal stromal tumors. Dis Markers. 2015:1710352015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng Z, Zheng M, Bi J, Feng Q, Yue Z,
Zhou Y, Hu W, Zhang H and Gao H: Serum GROβ: A potential
tumor-associated biomarker for colorectal cancer. Int J Clin Exp
Med. 8:2526–2535. 2015.PubMed/NCBI
|
|
13
|
Dong QM, Zhang JQ, Li Q, Bracher JC,
Hendricks DT and Zhao XH: Clinical significance of serum expression
of GROβ in esophageal squamous cell carcinoma. World J
Gastroenterol. 17:2658–2662. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bruyère C, Lonez C, Duray A, Cludts S,
Ruysschaert JM, Saussez S, Yeaton P, Kiss R and Mijatovic T:
Considering temozolomide as a novel potential treatment for
esophageal cancer. Cancer. 117:2004–2016. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang B, Hendricks DT, Wamunyokoli F and
Parker MI: A growth-related oncogene/CXC chemokine receptor 2
autocrine loop contributes to cellular proliferation in esophageal
cancer. Cancer Res. 66:3071–3077. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng Z, Zheng M, Bi J, Feng Q, Yue Z,
Zhou Y, Hu W, Zhang H and Gao H: Serum GROβ: A potential
tumor-associated biomarker for colorectal cancer. Int J Clin Exp
Med. 8:2526–2535. 2015.PubMed/NCBI
|
|
17
|
Li Y, Wang Y and Zhang P: Clinical
significance of serum expression of GROβ in hepatocellular
carcinoma. Tumour Biol. 36:6445–6449. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dong QM, Zhang JQ, Li Q, Bracher JC,
Hendricks DT and Zhao XH: Clinical significance of serum expression
of GROβ in esophageal squamous cell carcinoma. World J
Gastroenterol. 17:2658–2662. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thompson L: World Health Organization
classification of tumours: Pathology and genetics of head and neck
tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
|
|
20
|
Webber C, Gospodarowicz M, Sobin LH,
Wittekind C, Greene FL, Mason MD, Compton C, Brierley J and Groome
PA: Improving the TNM classification: Findings from a 10-year
continuous literature review. Int J Cancer. 135:371–378. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang J, Fan X, Wang X, Lu Y, Zhu H, Wang
W, Zhang S and Wang Z: High ROR2 expression in tumor cells and
stroma is correlated with poor prognosis in pancreatic ductal
adenocarcinoma. Sci Rep. 5:129912015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Wang C, Zhang Y, Jia L and Huang J:
Overexpression of MAGE-A9 Is predictive of poor prognosis in
epithelial ovarian cancer. Sci Rep. 5:121042015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen R, Lu M, Wang J, Zhang D, Lin H, Zhu
H, Zhang W, Xiong L, Ma J, Mao Y, et al: Increased expression of
Trop2 correlates with poor survival in extranodal NK/T cell
lymphoma, nasal type. Virchows Arch. 463:713–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han L, Jiang B, Wu H, Wang X, Tang X,
Huang J and Zhu J: High expression of CXCR2 is associated with
tumorigenesis, progression and prognosis of laryngeal squamous cell
carcinoma. Med Oncol. 29:2466–2472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu H, Lu J, Wang X, Zhang H, Tang X, Zhu
J and Mao Y: Upregulated ZO-1 correlates with favorable survival of
gastrointestinal stromal tumor. Med Oncol. 30:6312013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Welsh JB, Sapinoso LM, Kern SG, Brown DA,
Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, et
al: Large-scale delineation of secreted protein biomarkers
overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA.
100:3410–3415. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han L, Jiang B, Wu H, Zhang S and Lu X:
Expression and prognostic value of MAGE-A9 in laryngeal squamous
cell carcinoma. Int J Clin Exp Pathol. 7:6734–6742. 2014.PubMed/NCBI
|
|
29
|
Charo IF and Ransohoff RM: The many roles
of chemokines and chemokine receptors in inflammation. N Engl J
Med. 354:610–621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ebnet K and Vestweber D: Molecular
mechanisms that control leukocyte extravasation: The selectins and
the chemokines. Histochem Cell Biol. 112:1–23. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang B, Khachigian LM, Esau L, Birrer MJ,
Zhao X, Parker MI and Hendricks DT: A key role for early growth
response-1 and nuclear factor-kappaB in mediating and maintaining
GRO/CXCR2 proliferative signaling in esophageal cancer. Mol Cancer
Res. 7:755–764. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang D, Yang W, Du J, Devalaraja MN, Liang
P, Matsumoto K, Tsubakimoto K, Endo T and Richmond A:
MGSA/GRO-mediated melanocyte transformation involves induction of
Ras expression. Oncogene. 19:4647–4659. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Belperio JA, Keane MP, Arenberg DA,
Addison CL, Ehlert JE, Burdick MD and Strieter RM: CXC chemokines
in angiogenesis. J Leukoc Biol. 68:1–8. 2000.PubMed/NCBI
|
|
34
|
Loukinova E, Dong G, Enamorado-Ayalya I,
Thomas GR, Chen Z, Schreiber H and Van Waes C: Growth regulated
oncogene-alpha expression by murine squamous cell carcinoma
promotes tumor growth, metastasis, leukocyte infiltration and
angiogenesis by a host CXC receptor-2 dependent mechanism.
Oncogene. 19:3477–3486. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han L, Liu W, Chen Y, Wu H, Zhang Y and
Jiang B: GROα expression and its prognostic implications in
laryngeal squamous cell carcinoma. Neoplasma. 62:152–158. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Doll D, Keller L, Maak M, Boulesteix AL,
Siewert JR, Holzmann B and Janssen KP: Differential expression of
the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and
their impact on metastatic disease and survival. Int J Colorectal
Dis. 25:573–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dong Q, Zhang J, Hendricks DT and Zhao X:
GROβ and its downstream effector EGR1 regulate cisplatin-induced
apoptosis in WHCO1 cells. Oncol Rep. 25:1031–1037. 2011.PubMed/NCBI
|
|
38
|
Ye Q, Zhai X, Wang W, Zhang S, Zhu H, Wang
D and Wang C: Overexpression of growth-related oncogene-β Is
associated with tumorigenesis, metastasis and poor prognosis in
ovarian cancer. Dis Markers. 2015:3873822015. View Article : Google Scholar : PubMed/NCBI
|
